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Abstract 
Recently, much attention has been given to the use of innovative solution for the treatment of infected wounds in 
animals. Current applied treatments are often un-effective leading to infection propagation and animal death. Novel 
engineered membranes based on chitosan (CS) can be prepared to combine local antimicrobial effect, high flexibility 
and easy manipulation.  
In this work, CS crosslinked porous membranes with improved antimicrobial properties were prepared via freeze-drying 
technique to promote wound healing and to reduce the bacterial proliferation in infected injuries. Silver nanoparticles 
(AgNPs) and gentamicin sulphate (GS) were incorporated into the CS matrices to impart antibacterial properties on a 
wild range of strains. CS based porous membranes were tested for their physicochemical, thermal, mechanical as well 
as swelling and degradation behavior at physiological condition. Additionally, GS release profile was investigated, 
showing a moderate burst effect in the first days followed by a decreasing release rate which was maintained for at least 
56 days. Moreover, porous membranes loaded with GS or AgNPs showed good bactericidal activity against both of 
gram-positive and gram-negative bacteria. The bacterial strains used in this work were collected in chelonians after 
carapace injuries to better mimic the environment after trauma. 
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1. Introduction 
Infected injures are very common in animals and the recurring bacterial proliferation on the wound site may lead to 
animal’s death for a variety of reasons, including internal hemorrhage, organ damage and sepsis. One common 
occurrence of infection-related animal death is the shell trauma of chelonians. 
Shell trauma is one of the most common pathological conditions encountered in chelonians and it occurs with different 
seriousness degrees [1]. Carapace injuries arise mostly from dog bites, automobile and mower accidents, but can also 
result from falls [1]. Shell trauma may result in shell fractures with or without loss of bone tissue. In case of shell 
fracture without loss of bone tissue, closure of the fracture is usually enough to permit resolution of the wound while in 
case of severe fracture with loss of bone tissue, it is necessary to replace –at least temporarily- the tissue loss, as it will 
not regenerate spontaneously [2]. To treat chelonian carapace injuries, two clinical approaches are currently employed: 
i) the immediate closure of the shell by means of screws, plates and bone cements or epoxy resins [1, 3-7] or ii) the 
periodical direct medication of the wound through wet-to-dry bandages [1, 8], vacuum assisted closure (VAC) [9, 10], 
platelet-rich-plasma (PRP) treatment [11, 12] or ointments [13, 14]. In the former, the external fixation by means of 
screws and bone plates is used when wound contamination and infection have been prevented and there is no loss of 
bone tissue [15, 16] while cements/ epoxy resins are applied to fill bone missing zone [6, 7, 14, 17]. However, epoxy 
resins may cause an excessive tissue heating due to the exothermic nature of the resin polymerization process, they may 
require potentially toxic solvents for their removal [18] and they may increase the risk of contaminations that results in 
infection and sepsis [19]. In the latter treatment, turtle wound is left open in order to periodically disinfect and medicate 
it. Wet-to-dry bandages are generally used: the primary layer of gauzes is moist with sterile saline or dilute antiseptic 
solution and is allowed to dry out before its removal; however, dry gauzes are preferred in the presence of wound 
exudates and lets out necrotic tissue or debris [20]. However, there are many drawbacks associated with bandages, such 
as the damage of healthy tissue, the presence of disperse bacteria and fibers in the wound bed after the removal of 
gauzes [10]. The use of VAC technology consists on the application of an open-cell foam over the wound, secured to 
the site with adhesive occlusive drape, to which a suction system is attached [9]. With a constant negative pressure of 
about 125 mmHg [1] fluids can be collected from the wound permitting the exudate and bacteria removal and 
granulation tissue formation [21]. Disadvantages include the initial price and the need of proper training to use the 
equipment. Moreover, VAC technology is unsuitable in the case of a gross infection, lack of wound haemostasis, 
unprotected vascular anastomoses, foam placement over vessels, the presence of necrotic tissue with scar, exposed 
organs and malignancy in the wound bed [22]. PRP is a platelet concentrate derived from blood centrifugation 
procedures [11] which locally delivers high amounts of growth factors involved in haemostasis and cell proliferation 
(fibroblasts, osteoblasts, endothelial cells), promoting the wound healing process [23]. PRP gel must be applied onto the 
wound surface and is to be protected by a sterile gauze for 48 hours [12], working as a barrier against external 
microorganisms. Disadvantages of this technique include the need of an initial investment, the need of a proper training 
to use the equipment and the lack of a thorough understanding of the biologic interactions among PRP gel and the 
animal tissue. Among ointments, honey and sugar, petroleum impregnated gauzes, triple antibiotic ointment, GS cream 
and a variety of silver based products have been widely used in managing chelonian shell wound to prevent infection, 
maintain moisture, enhance healing, or facilitate debridement [14, 24]. Silver (Ag) is known for its broad antibacterial 
spectrum; it can be used as ointment and cream (silver sulfadiazine) [8], or it can be loaded in matrices as nanoparticles 
for its controlled release [25, 26]. Unfortunately, even if it shows an high antimicrobial activity, Ag has a potential toxic 
effect at higher dosage [27]. On the contrary, honey and sugar are cheaper and effective against a wide variety of Gram-
positive and Gram-negative bacteria, explicating their action by hydrogen peroxide release [28, 29]. GS also exherts 
antibacterial effects against both Gram-positive and Gram-negative bacteria [30] but it has a potential nephrotoxic effect 
depending on its concentrations [31].  
In this contest, skin tissue engineering (TE) could be a promising alternative approach to treat chelonian shell injuries 
and recently few studies have been reported [14, 32]. The final aim of the TE scaffold is to protect the injury during the 
regeneration process and to improve dermal and epidermal tissue regeneration [33]. The implantation of biodegradable 
membranes is encourage  since they completely cover the wound site, avoiding dirt and bacterial infiltration, and their 
removal is not required at the end of the treatment due to the material biodegradability [33]. Moreover, biodegradable 
membranes can act as drug delivery systems loading antibiotic agents that are locally released during membranes 
degradation [34]. The localized drug release achieved using biodegradable membranes guarantees lower antibiotic 
concentrations compared to systemic therapy due to the direct drug release in the wound site, thus assuming a lower 
toxicity. Alginates, hydrocolloids, hydrogels and foams are the most popular wound dressing in veterinary applications 
[20]. Among the natural polymers, CS (alone or coupled with antimicrobial or antibiotic agents) has been widely used 
in wound management both in humans and animals [35, 36]. 
In this study, CS based porous membranes with improved antimicrobial properties were developed to promote the 
wound healing process and to reduce the bacterial proliferation in chelonian shell injury site. To improve the 
mechanical properties and water stability of CS, dibasic sodium phosphate (DSP) and (3-
Glycidoxypropyl)methyldiethoxysilane (GPTMS) were used as crosslinking agents. Furthermore, GS and AgNPs were 
loaded into the developed membranes to improve the antibacterial effect against Gram-positive and Gram-negative 
bacteria and to guarantee drug controlled release in time and in space without exceeded the toxic dosage for systemic 
circulation. The obtained porous membranes were analyzed for their physicochemical and morphological properties by 
scanning electron microscopy (SEM), Energy Dispersive X-ray Spectrometry (EDS) and  thermogravimetric analysis 
(TGA) while their mechanical properties were evaluated by tensile and compressive tests. Swelling and dissolution 
degree were measured in media simulating physiological conditions. GS release from CS porous membranes was 
evaluated by means of UV-VIS spectroscopy, while the AgNPs release was indirectly investigated through in vitro 
antibacterial tests using five different bacteria lineages: Staphylococcus aureus (Gram-positive), Escherichia coli 
(Gram-negative) Enterococcus faecalis (Gram-positive), Pseudomonas aeruginosa (Gram-negative) and Proteus 
mirabilis (Gram-negative). 
 
2. Experimental 
2.1 Materials 
CS (medium molecular weight, 75%-85% deacetylation degree), GPTMS, DSP, GS and AgNPs (<110 nm particle size) 
were supplied from Sigma Aldrich. All solvents used were of analytical grade and used without further purification. 
2.2 Methods 
CS was dissolved in acetic acid solution 0.5M to form a CS solution of 2.5% w/v. Four different typologies of CS based 
membranes were prepared according to the following procedures: 
i. CS/GPTMS_DSP were obtained by adding GPTMS and DSP to the CS solution. GPTMS (50% w/w) was added to 
the CS solution and kept under magnetic stirring for about 1 hour. Afterward, DSP 1M solution (7.5 % v/v) was 
added dropwise to CS/GPTMS blend (one drop per second), maintained under stirring for about 10 minutes 
(CS/GPTMS_DSP).  
ii. Membranes incorporating the antibiotic agent (CS/GPTMS_DSP_GS) were fabricated as follow. GS was dissolved 
in ultrapure water to obtain a solution with concentration of 3.5 mg/ml; then, the GS solution was poured dropwise 
onto the surface of CS/GPTMS_DSP porous membranes allowing its homogeneous absorption into the CS matrix. 
Finally, CS/GPTMS_DSP_GS samples were cooled down a second time at -20°C for 24 hours and then freeze-
dried for 48 hours depending on the thickness of membranes. 
iii. CS/GPTMS_DSP_AgNPs samples were obtained by adding AgNPs to CS/GPTMS_DSP solution. Three different 
amounts of AgNPs respect to the total amount of CS were added: 5%, 10% and 15% w/w 
(CS/GPTMS_DSP_AgNPs5, CS/GPTMS_DSP_AgNPs10 and CS/GPTMS_DSP_AgNPs15 respectively). Once 
AgNPs were incorporated, the solutions were kept under magnetic stirring till their homogeneity was reached. 
Then, CS/GPTMS_DSP and CS/GPTMS_DSP_AgNPs solutions were poured in different molds: 1) multiwell (2 
ml in each well for compressive tests, 1 ml for the in vitro tests); 2) 10 cm-diameter Petri dishes (20 ml each) to 
obtain 2 mm thickness membranes for in vivo test; and 3) 12x12 cm-squared Petri dishes (90 ml) to obtain 5 mm 
thickness membranes for antibacterial tests. Once poured, samples were placed in a freezer at -20°C for 24 hours 
and then freeze-dried at -55°C for minimum 24 hours (48 hours for membranes with 5 mm thickness). 
2.3 Sample characterization 
2.3.1 Morphological characterization and element distribution 
The external surface and fractured (in liquid nitrogen) sections morphology of CS/GPTMS_DSP, 
CS/GPTMS_DSP_AgNP5, CS/GPTMS_DSP_AgNP10, CS/GPTMS_DSP_AgNP15 and CS/GPTMS_DSP_GS porous 
membranes was observed by SEM (SEM LEO – 1430, Zeiss). Samples were sputter coated with gold in a undervacuum 
chamber prior to SEM-EDS examination. 
Pore size was measured by analyzing the SEM images using an image software (ImageJ 1.43) and ten images for 
sample type were used. The ImageJ software measured the pore area; the pore size was calculated considering the pores 
as having circular shape with the same above measured area. Energy dispersive spectrometer (EDS) was applied to 
perform qualitative compositional analysis and the  punctual elemental composition of materials with high spatial 
resolution was obtained. 
 
2.3.2 Thermogravimetric analysis (TGA) 
Thermal degradation was measured using a TA INSTRUMENT Q500 equipment to investigate the  interaction between 
CS/GPTMS_DSP and the two antibacterial agents (AgNPs and GS) in terms of physic-chemical properties of the 
different samples. The experiments were performed with a 10-15 mg sample in aluminum pans under a dynamic 
nitrogen atmosphere between 40°C and 800 C. The experiments were run at a scanning rate of 10°C/min and obtained 
results were analyzed using TA Universal Analysis software. 
2.3.3 Mechanical properties  
Mechanical tests were performed to assess the mechanical behaviour of the membranes after implantation (flexibility, 
ability to cover the irregular shape of the trauma zone). Samples were tested in wet state since the in vivo implantation 
procedure on chelonians requires to soak the membranes with sterile 0.9% NaCl solution before application. In addition, 
the release of exudates from wound site in time maintains the developed scaffold in a moist environment. To have wet 
state, specimens were immersed in PBS (pH 7.4) for 10 minutes before testing. Both tensile and compressive tests were 
performed using MTS QTest/10 device equipped with load cells of 10 N and 50 N, respectively.  
2.3.3.1 Tensile test 
Rectangular strips of 10x30 mm size were cut from each typology of membranes. Then, samples were strained to break 
at a constant crosshead speed of 2 mm/min. Using the associated software Test Works, stress-strain curves were 
obtained, in which the elastic modulus was calculated from the slope of the first linear portion. To measure the 
thickness of the strips, digital calibrator was used and thicknesses were employed for determining the stress value. Four 
specimens for each kind of material were tested. The result was expressed as an average value ± standard deviation. 
2.3.3.2 Compressive test 
The compressive mechanical properties were performed on wet porous cylindrical scaffolds (1.2 cm diameter, 1cm 
height). All samples were compressed at a constant crosshead speed of 2 mm/min to approximately 80% of their 
original length. Four specimens for each kind of scaffold were tested. Young’s modulus (E), collapse strength and strain 
(σ* and ε*, respectively) and collapse modulus (E*) were measured from the stress-strain curves. E is the slope of the 
linear elastic regime, E* is the slope of the collapse regime, σ* and ε* are respectively the stress and strain of transition 
from linear to collapse regime (determined from the intersection of E and E* regression lines). The resulted values were 
expressed as an average value± standard deviation. 
2.3.4 Water uptake and dissolution tests 
The water uptake and dissolution behavior of porous samples were evaluated by immerging the samples in PBS (pH 
7.4) at 37°C. The water uptake degree was measured after 1, 3, 6, 9 and 24 hours while the dissolution degree was 
evaluated after 1, 3, 5, 7, 14, 28 and 56 days. The water uptake percentage was calculated as: 
ΔWs (%) = (Ws-W0)/W0*100 
where W0 and WS are the sample weights before and after swelling respectively. The dissolution percentage was 
calculated as: 
ΔWd (%) = (W0-Wd)/W0*100 
where Wd is the dried sample weight after dissolution. The solution pH was measured at the same time intervals during 
the swelling and the dissolution tests, and its stable value at around 7 (physiological pH) was verified. For each 
experimental time, three samples were measured and the results were expressed as averages value ± standard deviation. 
2.3.5 GS release quantification 
GS release from CS/GPTMS_DSP_GS membranes were carried out by UV-VIS spectroscopy (CARY 500 SCAN UV-
VIS-NIR Spectrophotometer). Samples were immersed in 5 ml of PBS at pH 7.4 and GS concentration in the incubation 
media was measured after 1, 3, 6, 24 hours and 2, 7, 14, 28, 56 days. The GS release concentration was reported as a 
percentage respect to the initial concentration and it was calculated from the absorption values using the calibration 
curves that was prepared starting from GS solutions of known concentrations. UV spectra were recorded in a range of 
400-200 nm. Five measures for sample were used and the data were reported as mean value ± standard deviation. 
2.3.6 Antibacterial tests 
The antibacterial properties of CS/GPTMS_DSP, CS/GPTMS_DSP_GS and CS/GPTMS_DSP_AgNP10 were tested 
against five pathogenic bacteria isolated from turtles wound infection: Staphylococcus aureus, Escherichia coli, 
Enterococcus faecalis, Pseudomonas aeruginosa and Proteus mirabilis. Samples (5 mm thickness) were prepared for 
antibacterial tests. Strains were stored in tryptone soy broth (TSB, Oxoid, Milano) with 20% glycerol at -80°C until 
needed. For experimental use, the stock cultures were grown on tryptone soy agar (TSA, Oxoid) slants, then each strain 
2-3 colonies was transferred to 10 ml of TSB and incubated at 37°C for 18 hours to obtain early stationary phase cells. 
Cell cultures of each microorganism in stationary phase were diluted in TSB and incubated at 37°C until an optical 
density of 0.2x10
5
 colony-forming units (CFU/ml) at 600 nm was reached. Tubes with 10 ml of Mueller-Hinton broth 
(MHB, Oxoid) were inoculated with 100 µl of culture. Sample weighing 0.25 g were then cut into 1.5 cm
2 
pieces and 
added to each tube. The tubes were then incubated at 37 °C for 18 hours. Depending on the turbidity of the tubes, serial 
dilutions with peptone water were made and plated in Petri dishes with 15 mL of TSA culture medium. Colonies (CFU) 
were counted after incubation at 37 °C for 18 hours. Three replicate plates were used per each dilution of broth.  
2.3.7 Statistics 
Results were expressed as an mean ± standard deviation. Statistical significance was calculated using analysis of 
variance (ANOVA). A comparison between two means was analyzed using Tukey's test with statistical significance 
level set at p<0.05. 
Results and discussion 
3.1 Morphological characterization and element distribution 
In figure 1 the surfaces and the fractured sections of CS/GPTMS_DSP membranes loaded with AgNPs are reported. 
The Petri-side surface showed a more compact structure as compared to the air-side surface due to the contact with the 
polystyrene substrate that probably induced a compression of the pores (data not shown). All porous scaffolds showed a 
typical foam-like morphology with highly interconnected pores on the sections. Mean pore diameters of the fractured 
sections were 27.7±2.4 µm, 30±2.5 μm, 16±2.03 μm and 13±2.9 μm for CS/GPTMS_DSP, CS/GPTMS_DSP_AgNP5, 
CS/GPTMS_DSP_AgNP10 and CS/GPTMS_DSP_AgNP15 membranes. The pores showed a spherical shape and a 
decreasing size and density on the surface with increasing the initial AgNPs amount from 5 to 15 wt.%. 
SEM images of fracture sections and surfaces of CS/GPTMS_DSP and GS loaded samples are reported in figure 2. 
Spherical, interconnected pores were observed both on the surface and on the section of CS/GPTMS_DSP_GS having a 
pore size dimension of 26.7±1.2 μm. Microstructure remodelling of CS/GPTMS_DSP_GS surface occurred after the 
rehydration and re-lyophilization processes used for the GS loading treatment: new pores with higher size and 
formation of sheets on the surface (reducing the interconnectivity) compared to control samples were detected and were 
associated to the removal of ice crystals during the second freeze-drying step. SEM analysis also evidenced the 
deposition and homogeneous distribution of the antibiotic agent into the bulk of the scaffold (insert in figure 2D). 
Membrane pore size was investigated since pore distribution is known to affect cell and nutrient permeability. It has 
been reported that highly open porous polymer matrices are required for high-density cell infiltration, as well as 
sufficient nutrient and oxygen supply to the cells in the scaffold [37]. Pore sizes of 5-10 μm are favorable for 
vascularization while a multi-pore size membrane (212–250 μm, 250–300 μm, 355–500 μm) has been investigated to 
guarantee a better environment for cell proliferation, compared with the uniform-pore size scaffold [37]. On the basis of 
these considerations, CS/GPTMS_DSP_AgNP5, CS/GPTMS_DSP_AgNP10 and CS/GPTMS_DSP_GS could be ideal 
candidate materials for the production of porous membranes for wound healing in chelionians. However, a selection of 
the optimal dressing also required an evaluation of the mechanical performance and of the water uptake behaviour of 
porous samples.  
EDS analysis was performed on CS/GPTMS_DSP, CS/GPTMS_AgNP5, CS/GPTMS_AgNP10 and 
CS/GPTMS_AgNP15 porous membranes to evaluate the distribution of AgNPs on the surfaces and sections of samples. 
Figure 3 reports the EDS element-mapping on the sections and surfaces for control and AgNPs loaded 
CS/GPTMS_DSP samples, respectively. EDS spectra of AgNPs loaded samples showed the characteristic elements of 
CS (C and O) and peaks corresponding to Si, Na and P elements associated both to the presence of GPTMS and DSP 
crosslinkers (data not shown). The green spots corresponding to Ag element were uniformly dispersed both on the 
sections (figure 3B, C, D) and surfaces (figure 3F, G, H) of CS/GPTMS_DSP_AgNPs5, CS/GPTMS_DSP_AgNPs10 
and CS/GPTMS_DSP_AgNPs15 samples.  
 
3.2 Thermogravimetric analysis (TGA) 
To further explore the interaction between CS/GPTMS_DSP and the two antibacterial agents (AgNPs and GS), the 
prepared membranes were characterized by TGA from 40°C to 800 C. The typical DGA curves of AgNPs and GS 
loaded membranes are reported in figures 4 and 5, respectively. Both the thermal curves clearly exhibited two 
distinctive thermal decomposition patterns (figure 4 and figure 5): the first decomposition step started from about 90°C 
and continued to above 150 °C and the second weight loss was observed in the temperature range between 180-550 °C. 
The initial thermal decomposition is mainly due to the evaporation of the water retained in the membranes and the 
second thermal event is attributed to the decomposition (oxidative and thermal) of the CS membrane matrix, which was 
completely destroyed around at temperature 550 °C. In addition, specimens exhibited small shoulders at 375 °C to 550 
°C associated with the thermal destruction of GPTMS and DSP used as crosslinkers. 
As shown in figure 4, after the addition of AgNPs, the onset temperature for the water evaporation and thermal 
decomposition of CS/GPTMS_DSP_AgNP5, CS/GPTMS_DSP_AgNP10 and CS/GPTMS_DSP_AgNP15 membranes 
delayed slightly to higher temperatures, indicating the increase in water holding capacity and thermal stability, which is 
mainly due to the presence of  heat stable metallic Ag [38] (figure 4). The residual percentages of weight for 
CS/GPTMS_DSP, CS/GPTMS_AgNP5, CS/GPTMS_AgNP10 and CS/GPTMS_AgNP15 were 48.3%, 58.4%, 56.5% 
and 57.2%, respectively, and they are mainly due to the formation of inorganic compounds after decomposition 
containing C, N and O and to the presence of Ag nanoparticles into membranes. Table 1 reports the maximum water 
evaporation temperature (Twe), the maximum degradation rate temperature (Td) of CS based samples and the 
corresponding weight losses. No differences were observed by increasing AgNPs amount from 5 to 15 wt. %. TGA 
analysis confirmed the improvement of the thermal stability of CS porous membranes after the addition of AgNPs. 
Figure 5 reports the DGA curve of control and CS/GPTMS_DSP_GS samples. The incorporation of GS into 
CS/GPTMS_DSP membranes did not affect the thermal behavior of samples. CS/GPTMS_DSP_GS showed a first 
thermal degradation at around 140 °C and a second stage, associated to the thermal and oxidative decomposition of CS 
and to the vaporization and elimination of volatile products, starting at 210 °C and reaching a maximum at 630 °C with 
a total weight loss of 43.7%. CS decomposition masked GS thermal degradation which is known to partially take place 
in the 200–500 C interval and to have a final oxidation between 500 °C and 650° C [39]. 
3.3 Mechanical properties 
Tensile and compressive tests were performed on wet state samples to mimic physiological environment and clinical 
procedures as, for the in vivo implantations on chelonians, membranes are soaked with 0.9 % NaCl solutions prior to 
implantation to have an increase in membranes flexibility resulting in an easy manipulation. 
 
3.3.1 Tensile test 
Tensile tests were performed on CS/GPTMS_DSP, CS/GPTMS_AgNP5, CS/GPTMS_AgNP10, CS/GPTMS_AgNP15 
and CS/GPTMS_DSP_GS porous membranes in wet conditions to determine the effect of the antibacterial agents on 
sample stiffness. All CS based membranes showed an elasto-plastic behaviour at low strains (lower than 10%) where 
stress values increased linearly with strain increase. For strains >10%, the stress increased slowly until failure occurred 
(data not shown).  
Addition of AgNPs resulted in a stiffening of the membranes (table 2) confirming the reinforcing effect of the 
nanoparticles in the polymeric matrix, which is consistent with literature data [38, 40]. In details, the elastic modulus of 
samples containing Ag nanoparticles differed significantly from the control (*p<0.05 for CS/GPTMS_DSP_AgNP5 and 
CS/GPTMS_DSP_AgNP10; **p<0.01 for CS/GPTMS_DSP_AgNP15). With increasing content of AgNPs, the E 
increased to a value ranging from 0.400-0.460 MPa (for CS/GPTMS_DSP_AgNP5 and CS/GPTMS_DSP_AgNP10) to 
1.834±0.693 MPa (CS/GPTMS_DSP_AgNP15). Moreover, CS/GPTMS_DSP_AgNP15 elastic modulus value was 
significantly different from CS/GPTMS_DSP_AgNP5 and CS/GPTMS_DSP_AgNP10 ones (*p<0.05 and **p<0.01 
respectively). The increase stiffness of CS/GPTMS_DSP_AgNP15 could be ascribed to the decrease of the degree of 
sample porosity caused by the higher amount of Ag nanoparticles. A significant increase (*p<0.05) of E value was also 
observed for CS/GPTMS_DSP_GS samples (1.180±0.560 MPa) compared to CS/GPTMS_DSP. This result is probably 
associated to the morphological changes caused by freeze-drying process after GS incorporation, as discussed in 
paragraph 3.1. 
All the investigated samples showed an high flexibility and an easy manipulation after immersion in physiological 
fluids. Furthermore, measured E values are in the range of 0.3-2.5 MPa comparable with the skin range value reported 
in the literature [41, 42] showing a biomimetic mechanical behaviour. 
 
 
3.3.2 Compressive test 
Figure 6 shows the compressive stress–strain curves for the AgNPs loaded CS/GPTMS_DPS porous scaffolds. 
CS/GPTMS_DSP containing Ag nanoparticles were characterized by a linear elastic regime at low deformations 
(elongation 0-10%) and a collapse regime at higher deformations (between 10- 20%). Samples did not reach final 
fracture and underwent densification. Data for wet CS/GPTMS_DSP specimens were not reported since load values 
were too low to be acquired by the equipment used. The addition of different amount of AgNPs showed an increase of 
the E and E* (table 3) by obtaining values around 0.030 MPa and 0.035 MPa for CS/GPTMS_DSP_AgNP5 and 
CS/GPTMS_DSP_AgNP10 to 0.070±0.012 MPa and 0.093±0.007 for CS/GPTMS_DSP_AgNP15. 
In addition, the stress and strain values of transition from linear to collapse regime (σ* and ε*) were observed for higher 
stress values (0.009±0.001 MPa for CS/GPTMS_DSP_AgNP5 to about 0.011 MPa for CS/GPTMS_DSP_AgNP10 and 
CS/GPTMS_DSP_AgNP15) and for increased elongations (from about 20 % for CS/GPTMS_DSP_AgNP5 and 
CS/GPTMS_DSP_AgNP10 to 12.848±2.640 for CS/GPTMS_AgNP15). The increase of E and E* values for 
CS/GPTMS_DSP_AgNP15 samples (statistical significant compared to CS/GPTMS_DSP_AgNP5 samples, *p<0.05) 
was due to the mechanical reinforcement associated with the addition of Ag nanoparticles and the decrease of sample 
porosity. 
The characteristic stress-strain curve of soft and porous materials was also observed for CS/GPTMS_DSP_GS samples 
(data not shown). After the introduction of GS to CS/GPTMS_DSP, E, E*, σ* and ε* were comparable to 
CS/GPTMS_DSP_AgNP15 obtaining values of 0.088±0.038 MPa, 0.093±0.029 MPa, 0.010±0.000 MPa and 
12.848±3.125 %, respectively (table 3). The structure modification following the incorporation of GS into the CS based 
porous membranes seem to affect the mechanical properties of samples. 
 
3.4 Water uptake and dissolution tests 
Water uptake and dissolution degree of CS/GPTMS_DSP samples loading Ag nanoparticles and GS are shown in figure 
7 and figure 8, respectively. 
Figure 7A reports the water uptake of CS/GPTMS_DSP, CS/GPTMS_DSP_AgNP5, CS/GPTMS_DSP_AgNP10 and 
CS/GPTMS_DSP_AgNP15. A comparison of the swelling percentage of AgNPs loaded samples to CS/GPTMS_DSP 
revealed that the water uptake was similar for all samples at each time point. In details, porous membranes increased 
considerably their weight immediately after 1 hour of immersion in PBS solution reaching values of water uptake of 
1219±19 %, 1356±9 %, 1174±126 % and 1150±193 %, for CS/GPTMS_DSP, CS/GPTMS_DSP_AgNP5, 
CS/GPTMS_DSP_AgNP10 and CS/GPTMS_DSP_AgNP15 respectively. Then, the swelling values remained stable till 
the end of the experiment. 
The dissolution profiles of AgNPs loaded CS based samples after 56 days of immersion in PBS are presented in figure 
7B. CS/GPTMS_DSP, CS/GPTMS_DSP_AgNP5, CS/GPTMS_DSP_AgNP10 and CS/GPTMS_DSP_AgNP15 
membranes decreased their weight of 11.0±2.0 %, 9.9±3.5 %, 9.0±0.7% and 11.6±2.0 % after 1 day incubation in PBS, 
respectively. The initial high weight loss was associated to the release of DSP salts into PBS solution. The weight loss 
values remained stable until14 days, then a moderate increase was measured after 28-56 days. Final dissolution values 
of 25.2±3.3 % for CS/GPTMS_DSP, 21.8±1.3 % for CS/GPTMS_DSP_AgNP5, 21.7±0.2 % 
CS/GPTMS_DSP_AgNP10 and 22.5±0.8 % for CS/GPTMS_DSP_AgNP15 were reached after 56 days incubation in 
PBS. No significant differences were observed between all samples at each time point. 
In figure 8A, the water uptake of porous membranes was measured to examine the changes of properties of 
CS/GPTMS_DSP in presence of GS. The water uptake of samples without GS was higher compared to 
CS/GPTMS_DSP_GS. The swelling degree of GS loaded CS/GPTMS_DPS reached values of 863±205 % after 1 hour 
incubation in PBS and a slightly increase was observed till 24 hours of immersion in physiological solution (973±165 
%). Significant differences were observed between control and CS/GPTMS_DSP_GS at the first two time points of 
experiment (*p< 0.05). The lower water absorption behavior of CS/GPTMS_DSP_GS is related to the microstructure 
remodeling of the surface that occurs after antibiotic agent loading.  
Figure 8B shows the percentage weight loss of CS/GPTMS_DSP and CS/GPTMS_DSP_GS membranes. A comparable 
weight reduction was measured for CS/GPTMS_DSP and CS/GPTMS_DSP_GS until 7 days. Then, at days 14, a 
significant differences compared to CS/GPTMS_DSP (***p<0.001) was measured and it can be attributed to the GS 
release from the polymer matrix that increased the weight loss of GS loaded membranes. On the contrary, after 56 days, 
samples containing GS showed a weight loss of about 20% while an higher degradation was measured for 
CS/GPTMS_DSP (*p<0.05). 
 
3.5 Drug release evaluation 
The GS release from CS/GPTMS_DSP porous membranes was evaluated in vitro quantifying the amount of GS in the 
collected medium. Figure 9 shows the cumulative release after 1, 3, 6 and 24 hours and at 2, 5, 7, 14, 28 and 56 days. 
An initial burst release was observed at 24 hours (about 70% with respect to the GS loaded into the membranes) 
followed by a moderate release over the subsequent days (around 0.55% each day). During the first 24 hours the release 
is mainly driven by diffusive mechanism and then, the CS/GPTMS_DSP_GS degradation allowed the release of a 
constant and moderate amount of GS. 
The local delivery of antibiotics at injured site is a preferred option to systemic administration since (i) it reduces the 
risk of systemic toxicity such as cell and organ toxicity [43, 44], (ii) it provides tissue compatibility and low occurrence 
of bacterial resistance [45] and (iii) it overcomes the problem of ineffective systemic antibiotic therapy resulting from 
poor blood circulation. The release kinetics measured for CS/GPTMS_DSP_GS membranes having a high initial GS 
release will enhance the antimicrobial effect, reducing the bacterial population on the wound site from the first day after 
implantation. 
 
3.6 Antibacterial tests 
In order to quantify the effect of GS and AgNPs on both Gram-negative (Escherichia coli, Pseudomonas aeruginosa 
and Proteus mirabilis) and Gram-positive (Staphylococcus aureus  Enterococcus faecalis) bacteria, time-killing assay 
was performed on CS/GPTMS_DSP, CS/GPTMS_DSP_GS and CS/GPTMS_DSP_AgNP10 by measuring the 
reduction of the number of CFU recovered at 18 hours. CS/GPTMS_DSP_AgNP10 samples were selected as optimized 
scaffolds since the AgNPs amount of 10 wt.%. was the highest loaded quantity that did not affect the sample porosity 
on the surface. Figure 10 shows the qualitative antibacterial efficacy exerted by the three membranes on Staphylococcus 
aureus. The results of the antibacterial screening of the tested scaffolds are presented in figure 11. The AgNPs 
impregnated CS membranes showed a bactericidal effect on all bacteria: growth of Staphylococcus aureus, Escherichia 
coli, Enterococcus faecalis, Pseudomonas aeruginosa and Proteus mirabilis was reduced by logarithmic orders of 3.4, 
1.5, 1.8, 2.3 and 1.6, respectively compared to CS/GPTMS_DSP. GS loaded CS/GPTMS_DSP membranes revealed 
total bactericidal activity against Escherichia coli, Staphylococcus aureus and Enterococcus faecalis but they were 
unable to inhibit bacterial propagation in case of Pseudomonas aeruginosa strain as compared to CS/GPTMS_DSP. 
Proteus mirabilis was reduced by logarithmic orders 1.27 respect to CS/GPTMS_DSP, showing results comparable to 
that obtained by CS/GPTMS_DSP_AgNP10. The most effective membrane against Escherichia coli, Staphylococcus 
aureus and Enterococcus faecalis strains was the one impregnated with GS, while the highest antibacterial activity 
against Pseudomonas aeruginosa was found for membranes containing AgNPs. The simultaneous loading of two agents 
(GS and AgNPs) on CS membranes will guarantee to improve the antibacterial effect against a broad spectrum of 
strains reducing the risk of infections that can consequently compromise the healing process. 
3. Conclusion 
Biodegradable wound dressings based on CS porous membranes with improved antimicrobial activities were developed 
to treat infected injures in animals. Chelonian shell injuries were selected as initial models to test the efficacy of this 
innovative treatment. Porous CS membranes containing GS or different ratios of AgNPs (5, 10 and 15% wt./wt.) were 
obtained by freeze-drying technique. Mechanical characterization was performed on samples showing that the 
incorporation of AgNPs or GS enhanced the stiffness of CS/GPTMS_DSP samples. Moreover, a strict correlation was 
observed between the Young modulus and the amount of AgNPs incorporated into the membranes: E increased as the 
AgNPs concentration incresed from 5% wt. to 15 wt.%. The high swelling degree, which is one of the important factor 
for reducing the risk of wound dehydration, was observed for all antimicrobial agent loaded samples reaching final 
values of about 1200-1300% and 950% for AgNPs and GS loaded membranes after 24 hours of incubation in 
physiological solution, respectively. However, the incorporation of the antimicrobial agents into CS/GPTMS_DSP 
affected the surface morphologies of porous membranes. Pore occlusion on the surface of CS based membranes 
containing AgNPs was detected increasing the amount of AgNPs. For this reason, CS/GPTMS_DSP_AgNP10 was 
selected as ideal candidate for this application field since it joins the good bacteriocide activities of Ag without affecting 
the CS based membranes structures as observed for 15% amount of Ag. After GS loading, new pores with higher size 
and formation of sheets on the surface (reducing the interconnectivity) were formed following rehydration and re-
lyophilization processes used for the GS loading treatment. GS release profile from CS/GPTMS_DSP_GS demonstrated 
high burst release of the antibiotics in the first 24 hours (about 70% with respect to the GS loaded into the membranes), 
followed by gradual release at a decreasing rate over time.  
Finally, GS and AgNPs (10% wt./wt.) effect on bacterial inhibition was investigated showing that the presence of either 
AgNPs or GS improved the antimicrobial activity of CS based porous membranes. GS loaded samples were highly 
efficient against Escherichia coli, Staphylococcus aureus and Enterococcus faecalis strains while 
CS/GPTMS_DSP_AgNP10 increased the inhibitory effect against Pseudomonas aeruginosa and Proteus mirabilis 
bacteria compared to control and GS loaded samples. Preliminary in vivo results showed effectiveness of the 
membranes [48]: CS/GPTMS_DSP_GS  membranes were implanted for 21 days on 12 Hermann’s tortoises (Testudo 
hermanni) with various shell injuries. Mould developed in two cases, and membranes were removed and re-implanted. 
All the animals recovered uneventfully [48]. Future works will be addressed to in vivo test of composite membranes 
based on CS impregnated with both AgNPs and antibiotics GS with the aim to improve the antibacterial activity against 
a broad spectrum of strains. 
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Figures 
 Figure 1. SEM micrographs of CS based membrane surfaces (A, C, E, G) and sections (B, D, F, H) after AgNPs addition: (A, B) 
CS/GPTMS_DSP; (C, D) CS/GPTMS_DSP_AgNP5; (E,F) CS/GPTMS_DSP_AgNP10; (G, H) CS/GPTMS_DSP_AgNP15. 
 
 
 Figure 2. SEM micrographs of CS/GPTMS_DSP (A,B) and CS/GPTMS_DSP_GS (C, D) membrane surfaces (A, C) and sections 
(B, D). Arrows indicated the presence of GS. 
 
 
Figure 3. EDS spectra of sections (A, B, C, D) and surfaces (E, F, G, H) of CS based porous membrane: (A, E) CS/GPTMS_DSP; 
(B, F) CS/GPTMS_DSP_AgNP5; (C, G) CS/GPTMS_DSP_AgNP10; (D, H) CS/GPTMS_DSP_AgNP15. Scale bar: 200 µm. Green 
spots represented Ag element. 
 
 
 
 Figure 4. First derivative of TGA curves of CS/GPTMS_DSP, CS/GPTMS_DSP_AgNP5, CS/GPTMS_DSP_AgNP10 and 
CS/GPTMS_DSP_AgNP15 porous membranes. 
 
 
Figure 5. First derivative of TGA curves of CS/GPTMS_DSP and CS/GPTMS_DSP_GS porous membranes. 
 
 
 
 Figure 6. Compression stress versus strain curves of CS/GPTMS_DSP_AgNP5, CS/GPTMS_DSP_AgNP10 and 
CS/GPTMS_DSP_AgNP15. Data for wet CS/GPTMS_DSP specimens were not reported since load value reached were too low to 
be acquired by the equipment used. 
 
 
Figure 7. Water uptake (A) and dissolution degree (B) of CS/GPTMS_DSP, CS/GPTMS_DSP_AgNP5, CS/GPTMS_DSP_AgNP10 
and CS/GPTMS_DSP_AgNP15 porous membranes in PBS as a function of time. Column heights correspond to the mean values. 
Bars indicate standard deviations (n = 3). 
  
 
Figure 8. Water uptake (A) and dissolution degree (B) of CS/GPTMS_DSP and CS/GPTMS_DSP_GS porous membranes in PBS as 
a function of time. Column heights correspond to the mean values. Bars indicate standard deviations (n = 3).*p< 0.05, ***p<0.001. 
 
 Figure 9. GS release after 1, 3, 6, 24 hours and 2, 5, 7, 14 , 28 and 56 days. The curve reports the percentage cumulative release 
values normalized respect to the initial amount of the GS incorporated within the CS/GPTMS_DSP_GS porous membranes. Markers 
correspond to the mean values. Bars indicate standard deviations (n = 3). 
 
 
 
 
Figure 10. S. aureus growth in contact with control (A), CS/GPTMS_DSP_GS (B) and CS/GPTMS_DSP_AgNP10 (C) membranes 
without MHB dilutions. 
 
Figure 11. Kinetics of growth inhibition of S. Aureus, E. Coli, E. Fecalis, P. aeruginosa and P. mirabilis in presence 
CS/GPTMS_DSP, CS/GPTMS_DSP_GS and CS/GPTMS_DSP_AgNP10. 
 Tables 
Table 1. Maximum water evaporation temperature (Twe), maximum degradation rate temperature (Td) and corresponding and total 
weight loss for CS based samples. 
Sample Twe 
(°C) 
Twe Weight 
loss (%) 
Td (°C) Td 
Weight loss 
(%) 
Total weight 
loss (%) 
CS/GPTMS_DSP 87.0 10.2 273 41.5 51.7 
CS/GPTMS_DSP_AgNP5 137.8 6.0 291.8 35.6 41.6 
CS/GPTMS_DSP_AgNP10 138.6 6.5 291.8 36.9 43.5 
CS/GPTMS_DSP_AgNP15 138.9 5.8 292.0 37.0 42.8 
 
 
 
Table 2. Elastic modulus calculated from the corresponding stress-strain curves of wet CS/GPTMS_DSP based samples (average 
value ± standard deviation). 
Sample Ewet (MPa) 
CS/GPTMS_DSP 0.085±0.010 
CS/GPTMS_DSP_AgNP5 0.405±0.185 
CS/GPTMS_DSP_AgNP10 0.397±4.14 
CS/GPTMS_DSP_AgNP15 1.834±0.693 
CS/GPTMS_DSP_GS 1.180±0.560 
 
 
 
Table 3 The elastic modulus (E), the collapse modulus (E*) and the collapse stress and strain (σ* and ɛ*, respectively) of 
CS/GPTMS membranes.  
Sample E (MPa) E* (MPa) σ* (MPa) ε*(%) 
CS/GPTMS_DSP_AgNP5 0.032±0.007 0.034±0.005 0.009±0.001 23.720±3.548 
CS/GPTMS_DSP_AgNP10 0.030±0.023 0.040±0.021 0.011±0.001 19.300±9.957 
CS/GPTMS_DSP_AgNP15 0.070±0.012 0.093±0.007 0.011±0.000 12.848±2.640 
CS/GPTMS_DSP_GS 0.088±0.038 0.093±0.029 0.010±0.000 12.848±3.125 
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